ERBB2 and breast carcinoma: Furthermore, to improvethe confidence in partners identified on cells, we determined enrichedproteins relative to a nonspecific membrane bound Ir-catalyst controlas opposed to the catalyst on the secondary antibody in solution.More than a dozen new candidate interacting partners for HER2 werediscovered with strong functional links to breast cancer.